Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 193.65
+4.65 (2.46%)
At close: Mar 25, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 84.52 billion as of March 27, 2026. Its market cap has increased by 122.58% in one year.
Market Cap
84.52B
Enterprise Value
89.49B
Revenue
18.17B
Ranking
n/a
PE Ratio
50.67
Stock Price
193.65
Market Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 84.52B, an increase of 24,203.75%. That is a compound annual growth rate of 29.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 84.52B | -6.81% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 210.39B |
| Granules India | 155.80B |
| Jubilant Pharmova | 136.99B |
| Rubicon Research | 127.45B |
| Caplin Point Laboratories | 121.29B |
| CORONA Remedies | 96.79B |
| Procter & Gamble Health | 81.99B |
| Sanofi India | 76.42B |